Drug Type Small molecule drug |
Synonyms EGIS 11004, S 36550 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H24ClN5O3 |
InChIKeyNTGVEJZKVATIPT-UHFFFAOYSA-N |
CAS Registry504397-21-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Preclinical | France | 15 Nov 2005 |